Positron-Emission Tomography
-
Subject Areas on Research
-
(18)F-Fluorothymidine PET-CT for resected malignant gliomas before radiotherapy: tumor extent according to proliferative activity compared with MRI.
-
(18)F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study.
-
18F-EF5 PET imaging as an early response biomarker for the hypoxia-activated prodrug SN30000 combined with radiation treatment in a non-small cell lung cancer xenograft model.
-
2-Deoxy-2-[18F] fluoro-D-glucose uptake in intercostal respiratory muscles on positron emission tomography/computed tomography: smokers versus nonsmokers.
-
3'-Deoxy-3'-[F-18]fluorothymidine positron emission tomography in patients with recurrent glioblastoma multiforme: comparison with Gd-DTPA enhanced magnetic resonance imaging.
-
4D offline PET-based treatment verification in scanned ion beam therapy: a phantom study.
-
A General Cutoff Level Combined With Personalized Dynamic Change of Serum Carcinoembryonic Antigen Can Suggest Timely Use of FDG PET for Early Detection of Recurrent Colorectal Cancer.
-
A case of curative-intent hepatectomy for colon cancer metastatic to the scapula and liver.
-
A multicenter prospective evaluation of the clinical utility of F-18 FDG-PET/CT in patients with AJCC stage IIIB or IIIC extremity melanoma.
-
A p-[18F]fluoroethoxyphenyl bicyclic nucleoside analogue as a potential positron emission tomography imaging agent for varicella-zoster virus thymidine kinase gene expression.
-
A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC).
-
A programmable smoke delivery device for PET imaging with cigarettes containing 11C-nicotine.
-
A simplified synthesis of the hypoxia imaging agent 2-(2-Nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-[(18)F]pentafluoropropyl)-acetamide ([18F]EF5).
-
A systematic review of the factors affecting accuracy of SUV measurements.
-
A technique of using gated-CT images to determine internal target volume (ITV) for fractionated stereotactic lung radiotherapy.
-
ACR-ASNR Practice Parameter for Brain PET/CT Imaging Dementia.
-
ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI.
-
ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy.
-
Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.
-
Accuracy of fluorodeoxyglucose-positron emission tomography within the clinical practice of the American College of Surgeons Oncology Group Z4031 trial to diagnose clinical stage I non-small cell lung cancer.
-
Accuracy of positron emission tomography in identifying hilar (N1) lymph node involvement in non-small cell lung cancer: Implications for stereotactic body radiation therapy.
-
Accurate event-driven motion compensation in high-resolution PET incorporating scattered and random events.
-
Adaptive planning using positron emission tomography for locally advanced lung cancer: A feasibility study.
-
Adrenal nodules at FDG PET/CT in patients known to have or suspected of having lung cancer: a proposal for an efficient diagnostic algorithm.
-
American Society of Clinical Oncology 2013 top five list in oncology.
-
Amyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals.
-
Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study.
-
Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research.
-
Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value.
-
Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease.
-
Approach to pediatric epilepsy surgery: State of the art, Part I: General principles and presurgical workup.
-
Are discordant positron emission tomography and pathological assessments of the mediastinum in non-small cell lung cancer significant?
-
Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults.
-
Association between amygdala reactivity and a dopamine transporter gene polymorphism.
-
Association of heat production with 18F-FDG accumulation in murine brown adipose tissue after stress.
-
Associations between dopamine D2 receptor availability and BMI depend on age.
-
Better late than early: FDG-PET imaging in metastatic renal cell carcinoma.
-
Brain connectivity and visual attention.
-
Brain nicotinic acetylcholine receptor availability and response to smoking cessation treatment: a randomized trial.
-
Brain nicotinic acetylcholine receptor occupancy: effect of smoking a denicotinized cigarette.
-
Brain trauma, PET scans and forensic complexity.
-
Can we improve the identification of ventricular scar to guide substrate-based ventricular tachycardia ablation?
-
Capacity for 5-HT1A-mediated autoregulation predicts amygdala reactivity.
-
Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts.
-
Changes in brain function occur years before the onset of cognitive impairment.
-
Characterization of 3-Dimensional PET Systems for Accurate Quantification of Myocardial Blood Flow.
-
Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors.
-
Classification and evaluation strategies of auto-segmentation approaches for PET: Report of AAPM task group No. 211.
-
Clinical imaging of vascular disease in chronic kidney disease.
-
Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer.
-
Clinical stage I non-small cell lung cancer including FDG-PET Imaging: sites and time to recurrence.
-
Clustered Arg-Gly-Asp peptides enhances tumor targeting of nonviral vectors.
-
Cognitive impact of genetic variation of the serotonin transporter in primates is associated with differences in brain morphology rather than serotonin neurotransmission.
-
Colocalization of gadolinium-diethylene triamine pentaacetic acid with high-molecular-weight molecules after intracerebral convection-enhanced delivery in humans.
-
Colonic schwannoma visualized on FDG PET/CT.
-
Colorectal liver metastasis after 90Y radioembolization therapy: pilot study of change in MDCT attenuation as a surrogate marker for future FDG PET response.
-
Combining multiple FDG-PET radiotherapy target segmentation methods to reduce the effect of variable performance of individual segmentation methods.
-
Commentary on "Positron Emission Tomography in the Lung" 25 years after publication in the inaugural issue of the Journal of Thoracic Imaging.
-
Commentary on imaging of bronchogenic carcinoma.
-
Comparative characteristics of primary hyperparathyroidism in pediatric and young adult patients.
-
Comparison of the Hypoxia PET Tracer (18)F-EF5 to Immunohistochemical Marker EF5 in 3 Different Human Tumor Xenograft Models.
-
Concurrent chemoradiotherapy for locally advanced, nonmetastatic, squamous carcinoma of the head and neck: consensus, controversy, and conundrum.
-
Connect MM Registry: The Importance of Establishing Baseline Disease Characteristics.
-
Continuing education course #1: non-invasive imaging as a problem-solving tool and translational biomarker strategy in toxicologic pathology.
-
Contouring variations and the role of atlas in non-small cell lung cancer radiation therapy: Analysis of a multi-institutional preclinical trial planning study.
-
Correlation of [18F]-2-fluoro-deoxy-D-glucose positron emission tomography standard uptake values with the cellular composition of stage I nonsmall cell lung cancer.
-
Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism.
-
Correspondence between in vivo (11)C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques.
-
Current trends in regional therapy for melanoma: lessons learned from 225 regional chemotherapy treatments between 1995 and 2010 at a single institution.
-
Current worldwide nuclear cardiology practices and radiation exposure: results from the 65 country IAEA Nuclear Cardiology Protocols Cross-Sectional Study (INCAPS).
-
Cutaneous γδ T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas.
-
Detection of primary breast carcinoma with a dedicated, large-field-of-view FDG PET mammography device: initial experience.
-
Diagnosing pulmonic valve infective endocarditis with positron emission tomography-CT.
-
Diagnostic accuracy of noninvasive testing: necessary but insufficient.
-
Digital anthropomorphic phantoms of non-rigid human respiratory and voluntary body motion for investigating motion correction in emission imaging.
-
Disparities in lung cancer staging with positron emission tomography in the Cancer Care Outcomes Research and Surveillance (CanCORS) study.
-
Does computed tomography or positron emission tomography response after neoadjuvant chemotherapy for resectable non-small-cell lung cancer predict survival?
-
Does myocardial perfusion imaging provide incremental prognostic information to left ventricular ejection fraction?
-
Dopamine in amygdala gates limbic processing of aversive stimuli in humans.
-
Dose-dependent effects of radiation therapy on cerebral blood flow, metabolism, and neurocognitive dysfunction.
-
Dosimetry and radiographic analysis of 131I-labeled anti-tenascin 81C6 murine monoclonal antibody in newly diagnosed patients with malignant gliomas: a phase II study.
-
Dramatic increase in autism prevalence parallels explosion of research into its biology and causes.
-
Early effects of imatinib mesylate on the expression of insulin-like growth factor binding protein-3 and positron emission tomography in patients with gastrointestinal stromal tumor.
-
Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis.
-
Effect of secondhand smoke on occupancy of nicotinic acetylcholine receptors in brain.
-
Effectiveness of Florbetapir PET Imaging in Changing Patient Management.
-
Efficacy of mediastinal lymph node dissection during lobectomy for lung cancer by thoracoscopy and thoracotomy.
-
Efficient purification and metabolite analysis of radiotracers using high-performance liquid chromatography and on-line solid-phase extraction.
-
Elective nodal irradiation for locally advanced non-small-cell lung cancer: it's called cancer for a reason.
-
Enhancing ejection fraction measurement through 4D respiratory motion compensation in cardiac PET imaging.
-
Estimation of D2-like receptor occupancy by dopamine in the putamen of hemiparkinsonian Monkeys.
-
Evaluating dopamine reward pathway in ADHD: clinical implications.
-
Evaluation of 5-(2-(4-pyridinyl)vinyl)-6-chloro-3-(1-methyl-2-(S)-pyrrolidinylmethoxy)pyridine and its analogues as PET radioligands for imaging nicotinic acetylcholine receptors.
-
Evidence for brain glial activation in chronic pain patients.
-
Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition).
-
Exercise heart rates in patients with hypertrophic cardiomyopathy.
-
FDG Uptake on Positron Emission Tomography Correlates with Survival and Time to Recurrence in Patients with Stage I Non-Small-Cell Lung Cancer.
-
FDG-PET assessment of the effect of head and neck radiotherapy on parotid gland glucose metabolism.
-
FDG-PET for management of cervical and ovarian cancer.
-
FDG-PET imaging in patients with pulmonary carcinoid tumor.
-
FDG-PET/CT characterization of adrenal nodules: diagnostic accuracy and interreader agreement using quantitative and qualitative methods.
-
Facility-level analysis of PET scanning for staging among US veterans with non-small cell lung cancer.
-
Feasibility of optimizing the dose distribution in lung tumors using fluorine-18-fluorodeoxyglucose positron emission tomography and single photon emission computed tomography guided dose prescriptions.
-
Fetal gene transfer with lentiviral vectors: long-term in vivo follow-up evaluation in a rat model.
-
First-in-man evaluation of 2 high-affinity PSMA-avid small molecules for imaging prostate cancer.
-
Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging.
-
Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study.
-
Fluorine-18 Labeling of the HER2-Targeting Single-Domain Antibody 2Rs15d Using a Residualizing Label and Preclinical Evaluation.
-
Four-dimensional image-based treatment planning: Target volume segmentation and dose calculation in the presence of respiratory motion.
-
Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies.
-
Functional and molecular image guidance in radiotherapy treatment planning optimization.
-
Gastrointestinal malignancies evaluated with (18)F-fluoro-2-deoxyglucose positron emission tomography.
-
Gender Differences in Radiation Dose From Nuclear Cardiology Studies Across the World: Findings From the INCAPS Registry.
-
Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB.
-
Greater nicotinic acetylcholine receptor density in smokers than in nonsmokers: a PET study with 2-18F-FA-85380.
-
Head and neck cancer as a model for advances in imaging prognosis, early assessment, and posttherapy evaluation.
-
Head and neck cancer: dedicated FDG PET/CT protocol for detection--phantom and initial clinical studies.
-
Hemispheric asymmetry of sulcus-function correspondence: quantization and developmental implications.
-
Hodgkin lymphoma, version 2.2015.
-
Human functional neuroimaging in nicotine and tobacco research: basics, background, and beyond.
-
I-131, I-123, and F-18 FDG-PET imaging in a patient with diffuse sclerosing variant of papillary thyroid cancer.
-
Imaging biomarker roadmap for cancer studies.
-
Imaging for assessment of radiation-induced normal tissue effects.
-
Imaging genetics of brain longevity and mental wellness: the next frontier?
-
Imaging of musculoskeletal bacterial infections by [124I]FIAU-PET/CT.
-
Imaging of primary and secondary renal lymphoma.
-
Imaging tumors of the penis and urethra.
-
Imaging-guided preoperative hookwire localization of nonpalpable extramammary lesions.
-
Impact of PET staging in limited-stage small-cell lung cancer.
-
Impact of consolidation radiation therapy in stage III-IV diffuse large B-cell lymphoma with negative post-chemotherapy radiologic imaging.
-
Impact of pre-operative positron emission tomography in gallbladder cancer.
-
Impact of pretreatment imaging on survival of esophagectomy after induction therapy for esophageal cancer: who should be given the benefit of the doubt?: esophagectomy outcomes of patients with suspicious metastatic lesions.
-
Impact of short access nicotine self-administration on expression of α4β2* nicotinic acetylcholine receptors in non-human primates.
-
Impact of ¹⁸F-florbetapir PET imaging of β-amyloid neuritic plaque density on clinical decision-making.
-
Impaired glucose tolerance in midlife and longitudinal changes in brain function during aging.
-
Improved cardiac risk assessment with noninvasive measures of coronary flow reserve.
-
Improved tumor targeting of anti-HER2 nanobody through N-succinimidyl 4-guanidinomethyl-3-iodobenzoate radiolabeling.
-
Improving outcomes in advanced DLBCL: systemic approaches and radiotherapy.
-
In Reply to Giron et al.
-
In vivo fibrillar beta-amyloid detected using [11C]PiB positron emission tomography and neuropathologic assessment in older adults.
-
In vivo noninvasive detection of Brown Adipose Tissue through intermolecular zero-quantum MRI.
-
In vivo treatment sensitivity testing with positron emission tomography/computed tomography after one cycle of chemotherapy for Hodgkin lymphoma.
-
Incidence and patterns of neuraxis metastases in children with diffuse pontine glioma.
-
Incidental Thyroid Nodules at Non-FDG PET Nuclear Medicine Imaging: Evaluation of Prevalence and Malignancy Rate.
-
Increasing uptake time in FDG-PET: standardized uptake values in normal tissues at 1 versus 3 h.
-
Influence of filter choice on 18F-FDG PET segmentation accuracy determined using generalized estimating equations.
-
Initial Performance of NI-RADS to Predict Residual or Recurrent Head and Neck Squamous Cell Carcinoma.
-
Integrating PET and CT information to improve diagnostic accuracy for lung nodules: A semiautomatic computer-aided method.
-
Integration of PET/MR Hybrid Imaging into Radiation Therapy Treatment.
-
Interpretation and reporting of positron emission tomography-computed tomographic scans.
-
Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone).
-
Intraarterial Microdosing: A Novel Drug Development Approach, Proof-of-Concept PET Study in Rats.
-
Is follow-up CT imaging of the chest and abdomen necessary after preoperative neoadjuvant therapy in rectal cancer patients without evidence of metastatic disease at diagnosis?
-
Ivory vertebra on 18F-sodium fluoride scan: an old sign in a new modality.
-
Journal Club: incidental thyroid nodules detected at imaging: can diagnostic workup be reduced by use of the Society of Radiologists in Ultrasound recommendations and the three-tiered system?
-
Kaposi sarcoma after bilateral lung transplantation.
-
Kinetics of brain nicotine accumulation in dependent and nondependent smokers assessed with PET and cigarettes containing 11C-nicotine.
-
Linking dementia research to policy: an example using fluorodeoxyglucose positron emission tomography for the diagnosis of Alzheimer's dementia and mild cognitive impairment.
-
Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder.
-
Low doses of alcohol substantially decrease glucose metabolism in the human brain.
-
Low-dose consolidation radiation therapy for early stage unfavorable Hodgkin lymphoma.
-
Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: a phase 2 randomized study.
-
MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis.
-
MR-PET co-registration in upper abdominal imaging: quantitative comparison of two different T1-weighted gradient echo sequences: initial observations.
-
MR-PET evaluation of 1-month post-ablation therapy for hepatocellular carcinoma: preliminary observations.
-
Management of Incidental Pituitary Findings on CT, MRI, and 18F-Fluorodeoxyglucose PET: A White Paper of the ACR Incidental Findings Committee.
-
Mapping the effects of ApoE4, age and cognitive status on 18F-florbetapir PET measured regional cortical patterns of beta-amyloid density and growth.
-
Measurement of the alpha4beta2* nicotinic acetylcholine receptor ligand 2-[(18)F]Fluoro-A-85380 and its metabolites in human blood during PET investigation: a methodological study.
-
Mechanistic Insights into Sympathetic Neuronal Regeneration: Multitracer Molecular Imaging of Catecholamine Handling After Cardiac Transplantation.
-
Melanoma-associated retinopathy: a presenting sign of metastatic disease.
-
Meta-analysis: the detection of pancreatic malignancy with positron emission tomography.
-
Meta-iodobenzylguanidine and analogues: chemistry and biology.
-
Metastatic melanoma to the heart.
-
Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder.
-
Midlife adiposity predicts earlier onset of Alzheimer's dementia, neuropathology and presymptomatic cerebral amyloid accumulation.
-
Modeling pathologic response of esophageal cancer to chemoradiation therapy using spatial-temporal 18F-FDG PET features, clinical parameters, and demographics.
-
Molecular PET imaging in multicenter Alzheimer's therapeutic trials: current trends and implementation strategies.
-
Molecular imaging for depressive disorders.
-
Molecular imaging of hypoxia.
-
Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway.
-
Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer.
-
Multisphere phantom and analysis algorithm for PET image quality assessment.
-
NIDA522131, a new radioligand for imaging extrathalamic nicotinic acetylcholine receptors: in vitro and in vivo evaluation.
-
Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates.
-
New advances in focal therapy for early stage prostate cancer.
-
New radiotherapy and chemoradiotherapy approaches for non-small-cell lung cancer.
-
Nuclear cardiology practice and associated radiation doses in Europe: results of the IAEA Nuclear Cardiology Protocols Study (INCAPS) for the 27 European countries.
-
Oncogene pathway activation in mammary tumors dictates FDG-PET uptake.
-
Operation of a radiopharmacy for a clinical trial.
-
PET and brain tumor image fusion.
-
PET appearance of tuberculous empyema necessitans.
-
PET of hypoxia and perfusion with 62Cu-ATSM and 62Cu-PTSM using a 62Zn/62Cu generator.
-
PET scanning in mild cognitive impairment.
-
PET with 62Cu-ATSM and 62Cu-PTSM is a useful imaging tool for hypoxia and perfusion in pulmonary lesions.
-
PET-CT: current applications and new developments in the thorax.
-
Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease).
-
Patterns of recurrence after trimodality therapy for esophageal cancer.
-
Pharmacodynamic study using FLT PET/CT in patients with renal cell cancer and other solid malignancies treated with sunitinib malate.
-
Pharmacological and toxicological evaluation of 2-fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-F-A-85380), a ligand for imaging cerebral nicotinic acetylcholine receptors with positron emission tomography.
-
PhytoBeta imager: a positron imager for plant biology.
-
Positron emission tomography in hepatobiliary and pancreatic malignancies: a review.
-
Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline.
-
Potential of immuno-positron emission tomography for tumor imaging and immunotherapy planning.
-
Practical approach to diagnostic CT combined with PET.
-
Preclinical activity profile and therapeutic efficacy of the HSP90 inhibitor ganetespib in triple-negative breast cancer.
-
Preclinical evaluation of 18F-JNJ41510417 as a radioligand for PET imaging of phosphodiesterase-10A in the brain.
-
Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers.
-
Predictive and prognostic role of functional imaging of head and neck squamous cell carcinomas.
-
Preliminary validation of varicella zoster virus thymidine kinase as a novel reporter gene for PET.
-
Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysis.
-
Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project.
-
Primary tumour standardised uptake value is prognostic in nonsmall cell lung cancer: a multivariate pooled analysis of individual data.
-
Prognostic significance of parameters derived from co-registered 18F-fluorodeoxyglucose PET and contrast-enhanced MRI in patients with high-grade glioma.
-
Prognostic value of 3'-deoxy-3'-18F-fluorothymidine ([(18)F] FLT PET) in patients with recurrent malignant gliomas.
-
Prognostic value of PET myocardial perfusion imaging in obese patients.
-
Prognostic value of Rb-82 positron emission tomography myocardial perfusion imaging in coronary artery bypass patients.
-
Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography imaging in patients with advanced-stage non-small-cell lung carcinoma.
-
Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry.
-
Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development.
-
Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases.
-
Prostate-Specific Membrane Antigen-Targeted Radiohalogenated PET and Therapeutic Agents for Prostate Cancer.
-
Quantification of alpha4beta2* nicotinic receptors in the rat brain with microPET and 2-[18F]F-A-85380.
-
Quantification of nicotinic acetylcholine receptors in the human brain with PET: bolus plus infusion administration of 2-[18F]F-A85380.
-
Quantitative effects of contrast enhanced CT attenuation correction on PET SUV measurements.
-
Quantitative imaging in oncology patients: Part 1, radiology practice patterns at major U.S. cancer centers.
-
Quantitative imaging in oncology patients: Part 2, oncologists' opinions and expectations at major U.S. cancer centers.
-
Radiofrequency ablation for primary lung cancer and pulmonary metastases.
-
Radiographic imaging of bronchioloalveolar carcinoma: screening, patterns of presentation and response assessment.
-
Radiolabeled inhibitors as probes for imaging mutant IDH1 expression in gliomas: Synthesis and preliminary evaluation of labeled butyl-phenyl sulfonamide analogs.
-
Radiosensitive orbital metastasis as presentation of occult colonic adenocarcinoma.
-
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease.
-
Real-Time Transferrin-Based PET Detects MYC-Positive Prostate Cancer.
-
Recent developments in predicting thyroid malignancy.
-
Recommendations on the use of 18F-FDG PET in oncology.
-
Redistribution of health care costs after the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2005.
-
Reduced effects of age on dopamine D2 receptor levels in physically active adults.
-
Regional brain activity correlates of nicotine dependence.
-
Regional cerebral blood flow and metabolic rate in persistent Lyme encephalopathy.
-
Regional cerebral glucose metabolism differentiates danger- and non-danger-based traumas in post-traumatic stress disorder.
-
Reply to "Prognostic Value of Fluorodeoxyglucose-Positron Emission Tomography".
-
Reply to M.S. Hofman et al.
-
Reply to M.S. Hofman et al.
-
Reply: Pharmacokinetic and Pharmacodynamic Modifiers of EF5 Uptake and Binding.
-
Safety of radial arterial catheterization in PET research subjects.
-
Safety profile and pharmacokinetic analyses of the anti-CTLA4 antibody tremelimumab administered as a one hour infusion.
-
Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with advanced cancer.
-
Selecting a noninvasive imaging study after an inconclusive exercise test.
-
Sex-specific effects of cigarette mentholation on brain nicotine accumulation and smoking behavior.
-
Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment.
-
Spatial-temporal [¹⁸F]FDG-PET features for predicting pathologic response of esophageal cancer to neoadjuvant chemoradiation therapy.
-
Spontaneous Eye Blink Rate (EBR) Is Uncorrelated with Dopamine D2 Receptor Availability and Unmodulated by Dopamine Agonism in Healthy Adults.
-
Stage migration, selection bias, and survival associated with the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2003.
-
Synthesis and biological evaluation of an 123I-labeled bicyclic nucleoside analogue (BCNA) as potential SPECT tracer for VZV-tk reporter gene imaging.
-
Synthesis and evaluation of 18F- and 11C-labeled phenyl-galactopyranosides as potential probes for in vivo visualization of LacZ gene expression using positron emission tomography.
-
Synthesis and evaluation of 18F-labeled benzylguanidine analogs for targeting the human norepinephrine transporter.
-
Synthesis and evaluation of 4-[18F]fluoropropoxy-3-iodobenzylguanidine ([18F]FPOIBG): A novel 18F-labeled analogue of MIBG.
-
Synthesis and preliminary evaluation of 18F- or 11C-labeled bicyclic nucleoside analogues as potential probes for imaging varicella-zoster virus thymidine kinase gene expression using positron emission tomography.
-
Synthesis and structure-activity relationship of a novel series of aminoalkylindoles with potential for imaging the neuronal cannabinoid receptor by positron emission tomography.
-
Synthesis, fluorine-18 radiolabeling, and in vitro characterization of 1-iodophenyl-N-methyl-N-fluoroalkyl-3-isoquinoline carboxamide derivatives as potential PET radioligands for imaging peripheral benzodiazepine receptor.
-
Synthetic positron emission tomography-computed tomography images for use in perceptual studies.
-
Technical considerations in radiation therapy for gastroesophageal junction cancer.
-
The Alzheimer structural connectome: changes in cortical network topology with increased amyloid plaque burden.
-
The development of a population of 4D pediatric XCAT phantoms for imaging research and optimization.
-
The immune response of the human brain to abdominal surgery.
-
The impact of radiation therapy in patients with diffuse large B-cell lymphoma with positive post-chemotherapy FDG-PET or gallium-67 scans.
-
The neurobiology of individual differences in complex behavioral traits.
-
The role of adaptive and functional imaging modalities in radiation therapy: approach and application from a radiation oncology perspective.
-
The role of endoscopy in the evaluation and management of patients with solid pancreatic neoplasia.
-
The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas.
-
The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study.
-
The value of diagnostic medical imaging.
-
The year in cardiovascular surgery.
-
Thoracic imaging.
-
Thyroid carcinoma: the surgeon's perspective.
-
Tracking radiation exposure of patients.
-
Treatment for tobacco dependence: effect on brain nicotinic acetylcholine receptor density.
-
Tumor blood flow measured by PET dynamic imaging of first-pass 18F-FDG uptake: a comparison with 15O-labeled water-measured blood flow.
-
Tumor blood flow measured by perfusion computed tomography and 15O-labeled water positron emission tomography: a comparison study.
-
Tumor necrosis and cavitation after stereotactic body radiation therapy.
-
Up-regulation of nicotinic acetylcholine receptors in menthol cigarette smokers.
-
Use of florbetapir-PET for imaging beta-amyloid pathology.
-
Using FDG-PET activity as a surrogate for tumor cell density and its effect on equivalent uniform dose calculation.
-
Using FDG-PET to measure early treatment response in head and neck squamous cell carcinoma: quantifying intrinsic variability in order to understand treatment-induced change.
-
Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease.
-
Using the 3-tiered system for categorizing workup of incidental thyroid nodules detected on CT, MRI, or PET/CT: how many cancers would be missed?
-
Utility of FDG PET/CT in inflammatory cardiovascular disease.
-
Utility of functional imaging in prediction or assessment of treatment response and prognosis following thermotherapy.
-
Validation of an extracerebral reference region approach for the quantification of brain nicotinic acetylcholine receptors in squirrel monkeys with PET and 2-18F-fluoro-A-85380.
-
Validation of consensus panel diagnosis in dementia.
-
Variable-time positron emission tomography leg protocol to equalize noise for positron emission tomography/computed tomography acquisitions.
-
Variations in use of PET among Medicare beneficiaries with non-small cell lung cancer, 1998-2007.
-
Ventilation defects observed with hyperpolarized 3He magnetic resonance imaging in a mouse model of acute lung injury.
-
What to do with incidental thyroid nodules identified on imaging studies? Review of current evidence and recommendations.
-
When is a biopsy-proven diagnosis necessary before stereotactic ablative radiotherapy for lung cancer?: A decision analysis.
-
[18F]-fluorodeoxyglucose positron emission tomography combined with computed tomography detection of asymptomatic late pulmonary toxicity in patients with non-Hodgkin lymphoma treated with rituximab-containing chemotherapy.
-
[18F]fluorodeoxyglucose-positron emission tomography in patients with medulloblastoma.
-
Keywords of People
-
Chitneni, Satish K.,
Associate Professor in Radiology,
Radiology
-
Curtis, Lesley H.,
Professor in Population Health Sciences,
Medicine, General Internal Medicine
-
Esclamado, Ramon Mitra,
Richard Hall Chaney, Sr. Professor of Otolaryngology, Head & Neck Surgery,
Surgery, Head and Neck Surgery and Communication Sciences
-
Hoang, Jenny K.,
Associate Professor of Radiology,
Radiology, Neuroradiology
-
McLendon, Roger Edwin,
Professor of Pathology,
Pathology
-
Palmer, Gregory M.,
Associate Professor of Radiation Oncology,
Radiation Oncology
-
Patz Jr., Edward F.,
James and Alice Chen Professor of Radiology,
Pathology
-
Sampson, John Howard,
Robert H., M.D. and Gloria Wilkins Professor of Neurosurgery, in the School of Medicine,
Immunology
-
Segars, William Paul,
Associate Professor in Radiology,
Radiology
-
Sullivan, Daniel Carl,
Professor Emeritus of Radiology,
Radiology
-
Turkington, Timothy Garvey,
Associate Professor in Radiology,
Radiology
-
Turner, Dennis Alan,
Professor of Neurosurgery,
Biomedical Engineering